Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by FTI Consulting .
Filed returns
30
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | FTI Consulting | Health | Minister Site Visit to Jazz Pharmaceuticals Manufacturing Facility in Athlone (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | FTI Consulting | Health | Minister Site Visit to Jazz Pharmaceuticals facility in Athlone (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | FTI Consulting | Health | Jazz Pharmaceuticals Introductory Outreach (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2024 | FTI Consulting | Health | Invitation to attend rescheduled Jazz Pharmaceutical event to mark 20th anniversary and 10 years in Athlone (Public policy or programme) | 16 | On lobbying.ie |
| Sep–Dec 2023 | FTI Consulting | Health | Jazz Pharmaceuticals' invitation to attend event marking its 20th anniversary (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2023 | FTI Consulting | Health | Medica email regarding diabetic retinopathy national screening service. (Matters involving public funds) | 3 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals requested a meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals virtual meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals virtual meeting to discuss Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2023 | FTI Consulting | Health | Jazz Pharmaceuticals contacted members of the Oireachtas requesting an introductory meeting about Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2022 | FTI Consulting | Health | Jazz Pharmaceuticals sent an email to Minister Stephen Donnelly and his advisers regarding the Medical Cannabis Access Programme (MCAP) Review to seek details on the format and timeline of the review and offer a meeting… (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2022 | FTI Consulting | Health | Jazz Pharmaceuticals sent an email to TDs and Senators requesting an introductory meeting about Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2022 | FTI Consulting | Health | Jazz Pharmaceuticals sent a follow up email to Deputy John Lahart regarding an introductory meeting about Jazz’s operations in Ireland and regulatory approved cannabis-based medicines. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2022 | FTI Consulting | Health | Jazz Pharmaceuticals held introductory meetings to discuss Jazz’s operations in Ireland and the Company’s approach to cannabinoid science and development of regulatory approved cannabis-based medicines. (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2022 | FTI Consulting | Health | Jazz Pharmaceuticals reached out to a number of DPO’s requesting an introductory meeting to discuss the Company’s approach to cannabinoid science and development of regulatory approved cannabis-based medicines. (Public policy or programme) | 16 | On lobbying.ie |
| Sep–Dec 2021 | FTI Consulting | Health | FTI Consulting sent a copy of a press release, on behalf of Jazz Pharmaceuticals, regarding the public announcement of HSE’s reimbursement of Epidyolex (Public policy or programme) | 18 | On lobbying.ie |
| May–Aug 2021 | FTI Consulting | Health | GW Pharmaceuticals sent a letter to An Taoiseach Micheal Martin with an offer to brief him on GW’s approach to developing regulatory approved cannabis-based medicines to patients. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | FTI Consulting | Health | GW Pharmaceuticals sent a letter in the context of membership of the Oireachtas Health Committee, to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | FTI Consulting | Health | GW Pharmaceuticals met with David Cullinane TD and Colm Burke TD, in the context of their membership of the Oireachtas Health Committee, to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | FTI Consulting | Health | GW Pharmaceuticals sent a letter to An Taoiseach Micheal Martin to request a meeting to discuss cannabinoid science and GW Pharmaceuticals in response to issues raised in the Dáil relating to GW’s Epidyolex. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | FTI Consulting | Health | GW Pharmaceuticals sent a letter to Minister Stephen Donnelly to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | FTI Consulting | Health | GW Pharmaceuticals sent a letter and follow-up to Minister Frank Feighan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | FTI Consulting | Health | GW Pharmaceuticals sent a letter to Alan Kelly TD to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | FTI Consulting | Health | GW Pharmaceuticals sent a letter to Minister Eamon Ryan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2020 | FTI Consulting | Health | GW Pharmaceuticals sent a letter to Minister Stephen Donnelly and Deputy Minister Frank Feighan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2019 | FTI Consulting | Health | Letter to Minister Harris to request a meeting to discuss cannabinoid science and GW Pharmaceuticals (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2018 | FTI Consulting | Health | Regulations on plain packaging of tobacco products (Legislation) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 30 | 100.0% |